Search this site

Explore arachnoid cysts with The Neurosurgical Case Room (TNCR), including classification, clinical presentation, imaging, natural history and principles of neurosurgical management. Arachnoid Cyst Q. What is an arachnoid cyst? An arachnoid cyst is a congenital, CSF-filled lesion arising from splitting or duplication of the arachnoid membrane. It is lined by arachnoid cells, contains fluid nearly identical to CSF, and displaces adjacent brain parenchyma, sometimes remodeling bone. It is not a neoplasm and is distinct from post-traumatic leptomeningeal cysts. Although arachnoid cysts may occur anywhere along the neuraxis, the most common sites are the middle cranial fossa, cerebellopontine angle, suprasellar region, and posterior fossa. Arachnoid cysts also occur in the spine. Q. What is the epidemiology of intracranial arachnoid cysts? Autopsy series report an incidence of approximately 1 per 500 persons. Arachnoid cysts comprise around 1% of all intracranial masses. They occur more commonly in males, with a male-to-female ratio of 4:1, and are more frequently found on the left side. Bilateral arachnoid cysts can occur, particularly in patients with metabolic disorders such as mucopolysaccharidoses. Q. What are the microscopic and histologic characteristics of arachnoid cysts? Two histological patterns exist: “Simple” arachnoid cysts show a delicate arachnoid lining with cells capable of minimal CSF secretion. Middle fossa cysts are almost always of this type. Complex cysts contain a mixed lining with potential mucin, ependyma, or other cell types, especially in unusual locations or syndromic patients. Arachnoid cysts are lined by epithelial membrane antigen–positive arachnoid cells and are negative for tumor markers such as CEA. Q. How are middle cranial fossa arachnoid cysts classified (Galassi)? The Galassi classification applies to Sylvian fissure/middle fossa cysts and contains three types: Type I: Small, anterior, biconvex cysts at the temporal tip, minimal mass effect, communicate freely with the subarachnoid space. Type II: Intermediate-sized cysts involving the proximal and intermediate Sylvian fissure; the insula is partly exposed; partial communication with the subarachnoid space is common. Type III: Large cysts occupying the entire middle cranial fossa, producing marked midline shift and bony expansion (elevation of sphenoid wing, outward displacement of squamous temporal bone). These have minimal communication with the subarachnoid space. Q. How are arachnoid cysts classified by location? Almost all arachnoid cysts occur in relation to an arachnoid cistern (intracisternal). The only exception is intrasellar cysts, which are extradural. Based on location, common sites include: • Sylvian fissure (most common, approximately half of all cysts) • CPA region • Supracollicular (quadrigeminal plate) • Vermian/posterior fossa • Sellar/suprasellar region • Interhemispheric fissure • Cerebral convexity • Clival • Spinal arachnoid space Q. How do arachnoid cysts form? They arise during embryogenesis from splitting or non-fusion of arachnoid membranes, creating a pocket that fills with CSF. They are therefore considered intra-arachnoid compartments. Fluid accumulates via CSF pulsation, passive diffusion, or a ball-valve effect. Secondary cysts may arise after infection, hemorrhage, trauma, or surgery; these have thickened walls or multiple septations. Q. What mechanisms allow arachnoid cysts to enlarge? Several mechanisms exist: A one-way valve leading to progressive CSF inflow Entrapment of CSF within an isolated arachnoid compartment Compression of adjacent arachnoid cisterns leading to unidirectional filling Intrinsic secretion from the cyst wall (rare) Impaired reabsorption or scarring of subarachnoid pathways Q. What is the importance of location in clinical presentation? Location determines which structures are compressed: Sylvian fissure: temporal lobe compression can lead to seizures and headaches Posterior fossa/vermis: hydrocephalus, ataxia Suprasellar: visual deficits, endocrine symptoms, precocious puberty, bobble-head doll syndrome, hydrocephalus Quadrigeminal plate: compression of posterior third ventricle can lead to obstructive hydrocephalus Convexity/interhemispheric: focal deficits, seizures Spinal: myelopathy, radicular pain Q. How do arachnoid cysts present clinically? Most are asymptomatic. Symptoms, when present, depend on location and cyst size. Typical presentations include: Intracranial hypertension: headache, nausea, vomiting, lethargy, irritability (especially in infants with large cysts). Seizures: particularly with middle fossa cysts due to temporal lobe irritation. Sudden deterioration: from intracystic or subdural hemorrhage (especially middle fossa cysts with tearing of bridging veins). Focal neurological deficit: due to space-occupying effect. Cosmetic skull deformity: outward bulging over the cyst. Incidental discovery: on imaging for unrelated issues. Suprasellar cysts have additional typical features: Hydrocephalus due to third ventricle/aqueduct compression Visual loss Endocrine disturbances including precocious puberty (occurs in up to 60%) “Bobble-head doll syndrome” (rare but classic), characterized by repetitive anteroposterior head movements Q. What CT features suggest an arachnoid cyst? CT shows a smooth, well-demarcated, non-calcified lesion with density nearly identical to CSF and no enhancement. Chronic cysts remodel adjacent bone in up to two-thirds of supratentorial and up to 80% of infratentorial cysts. The cyst may cause mass effect on adjacent structures, including lateral ventricle distortion or midline shift. Q. What MRI findings are characteristic of an arachnoid cyst? MRI is superior for evaluating cysts. The cyst follows CSF on all sequences: • Low T1, high T2 signal • Suppression on FLAIR • No diffusion restriction (epidermoids restrict) • No enhancement • Fine membranes may be visible on CISS/FIESTA sequences MRI can also show mass effect on the third/fourth ventricles, obstruction of foramina of Monro or aqueduct, and presence of septations. Q. What is the role of CT cisternography? CT cisternography involves the injection of intrathecal water-soluble contrast followed by high-resolution CT to evaluate contrast entry into the cyst. It is useful for: Determining communication between the cyst and subarachnoid space Differentiating true arachnoid cysts from loculated CSF spaces or diverticula Preoperative planning for fenestration (identifying best drainage pathways) Evaluation of intraventricular or posterior fossa cysts when MRI is inconclusive Confirming patency of a fenestration postoperatively Because some cysts only partially fill with contrast, interpretation must be correlated with MRI. Q. What are the treatment options for arachnoid cysts? Treatment depends on cyst location, size, symptoms, and communication with adjoining cisterns. Options include: Endoscopic fenestration into basal cisterns, ventricles, or both. Microsurgical fenestration via a craniotomy when endoscopic access is difficult or the cyst is multiloculated. Cystoperitoneal shunt as a definitive, low-recurrence option when other methods fail or are anatomically unsafe. Suboccipital or retrosigmoid fenestration for posterior fossa cysts. Spinal cyst fenestration or excision for intradural spinal lesions. Drainage alone (needle aspiration or burr hole) is avoided due to high recurrence. Ventricular drainage is contraindicated because it can worsen cyst enlargement. Q. What is the treatment of middle fossa arachnoid cysts? Middle fossa (Sylvian fissure) cysts are best treated by microsurgical fenestration into the basal cisterns, especially for large Type III lesions. Small, asymptomatic Type I lesions often require no treatment. Type II cysts may be treated with endoscopic fenestration when safe trajectories exist; however, microsurgical fenestration provides the most reliable and durable communication with the bulk cisterns. If fenestration fails or anatomy is unfavorable, cystoperitoneal shunting offers excellent long-term control and low recurrence. Q. What is the best treatment for suprasellar arachnoid cysts? The best and most durable treatment for suprasellar arachnoid cysts is endoscopic ventriculocystocisternostomy (VCC). This creates a wide communication between: The cyst The third ventricle The interpeduncular and prepontine cisterns VCC allows continuous CSF circulation and has the lowest recurrence rate among all treatments. Endoscopic ventriculocystostomy (VC) alone is less durable because it does not reestablish cisternal flow. Microsurgical subfrontal approaches are reserved for cases where endoscopic access is not possible. Q. What is the best treatment for posterior fossa arachnoid cysts? Posterior fossa cysts compressing brainstem or cerebellum are treated via a midline suboccipital or retrosigmoid fenestration into the cisterna magna or prepontine cistern. Endoscopic treatment is rarely feasible in posterior fossa due to limited endoscopic corridors. Q. What is the best treatment for intraventricular arachnoid cysts? These lesions are treated by neuroendoscopic fenestration into the ventricular system and adjacent cisterns. CT cisternography can help determine communication before surgery. Shunting is reserved for multiloculated or recurrent cysts. Q. How will you surgically treat an arachnoid cyst? (Microsurgical Fenestration) I will begin by reviewing high-resolution MRI, focusing on the cyst’s relationship to arteries, veins, cranial nerves, ventricles, and cisterns. Based on its location, I will select an optimal operative approach. For middle fossa cysts, I will commonly use a pterional craniotomy. For suprasellar cysts, I will plan a burr hole approach for neuroendoscopic ventriculocystocisternostomy. For posterior fossa lesions, I will choose a midline suboccipital or retrosigmoid exposure. After positioning and preparing the patient, I will open the dura and gently expose the cyst wall under the microscope or endoscope. I will cautiously dissect arachnoid membranes away from the cyst, protecting cortical vessels and perforators. Once I identify the cisternal or ventricular boundary, I will create a wide fenestration in the cyst wall using microscissors or bipolar forceps, ensuring a robust opening that cannot close spontaneously. If the cyst has internal septations, I will open each one to create a single cavity. For suprasellar cysts, I will identify the floor of the third ventricle, the lamina terminalis, and the interpeduncular cistern, and I will perform a ventriculocystocisternostomy to establish strong dual communication with both ventricle and cistern. I will confirm that CSF flow passes freely through the fenestrations and that no neural or vascular structures are entrapped. If the fenestration is not feasible or if the cyst is multiloculated and deep, I will place a cystoperitoneal shunt using a low-pressure valve to maintain gradual decompression. I will then irrigate, achieve hemostasis, and close all layers meticulously. Postoperatively, I will monitor for neurological improvement, signs of CSF leak, and subdural collections. Follow-up MRI will confirm cyst decompression and patency of fenestrations. Q. What are the perioperative complications of arachnoid cyst surgery? These include: Injury to adjacent cortex, cranial nerves, or perforator vessels Hemorrhage into the cyst or subdural space CSF leak Failure to adequately fenestrate cyst walls Injury to optic apparatus in suprasellar cases Brainstem injury in posterior fossa approaches Q. What are the postoperative complications? Postoperative complications include: Subdural hygroma (most common) due to rapid decompression of a large cyst Subdural hematoma Recurrence due to closure of fenestration Persistent hydrocephalus Shunt dependency if a shunt was placed Seizures in patients with temporal lobe involvement Visual or endocrine deterioration in suprasellar cysts if decompression is inadequate Q. How will you counsel the patient or parents before surgery? I will explain that arachnoid cysts are benign lesions that often remain stable, but surgery is indicated when symptoms or progressive enlargement occur. I will emphasize that the goal is to restore normal CSF circulation by fenestrating the cyst into cisterns or ventricles. I will discuss risks such as subdural collections, recurrence, cranial nerve deficits (depending on location), and the possibility of needing a shunt. For suprasellar cysts, I will clarify that endoscopic ventriculocystocisternostomy offers the best long-term results and carries a low recurrence rate. I will address seizure prognosis in temporal cyst cases and reassure parents that many children improve after decompression. Q. What is the prognosis after surgery for arachnoid cysts? Prognosis is excellent. Most symptomatic patients show significant improvement in headaches, hydrocephalus, visual symptoms, or developmental delay. Suprasellar cyst symptoms, especially visual decline and bobble-head doll syndrome, often improve dramatically with timely VCC. Recurrence is uncommon when wide fenestrations are created. Shunted cysts function well but require lifelong surveillance for shunt malfunction. Seizure control depends on underlying cortical pathology; some patients continue to require antiepileptic therapy despite cyst decompression. Reference: Greenberg's Handbook of Neurosurgery, 10th Edition

Coming Soon.

Meet TNCR Patrons Robert F. Spetzler, William T. Couldwell, Henry Marsh, and Mehmet Zileli, distinguished leaders supporting global neurosurgical education. Honorary International Patrons Henry Marsh, CBE, FRCS Neurosurgeon & International Bestselling Author Pioneer of Awake Brain Surgery · Honorary Professor, Romodanov Neurosurgery Institute Patron, The Neurosurgical Case Room Robert F. Spetzler, MD, FAANS Emeritus President & CEO · Emeritus Chair of Neurosurgery, Barrow Neurological Institute Harvey Cushing Medal, 2017 Cushing Award, 2021 Patron, The Neurosurgical Case Room William T. Couldwell, MD, PhD, FACS Professor & Chair of Neurosurgery, University of Utah Past President, AANS · AAcNS · WANS Harvey Cushing Medal, 2022 Patron, The Neurosurgical Case Room Mehmet Zileli, MD Professor of Neurosurgery, SANKO University Chair, WFNS Education & Training Committee Past Chair, WFNS Spine Committee · Past President, Turkish Neurosurgical Society Patron, The Neurosurgical Case Room

Explore brain tumors and tumor-like lesions with TNCR Review Notes, covering classification, pathology, clinical features, imaging, diagnosis and key principles of neurosurgical management. Cranial Tumors & Tumor-LIKE Lesions Clinoidal Meningioma → Pilocytic Astrocytoma → Colloid Cyst → Falcine Meningioma → Convexity Meningioma → Foramen Magnum Meningioma → Craniopharyngioma → Tuberculum Sella Meningioma → Hemangioblastoma → Intraventricular Meningioma → NF1, NF2, & Schwannomatosis → Olfactory Groove Meningioma → Parasagittal Meningioma → Petroclival Meningioma →

Review falcine meningioma with concise neurosurgical notes covering anatomy, clinical features, imaging, surgical approaches, management, and key exam points. Falcine Meningioma A falcine meningioma arises from the dura of the falx cerebri and is entirely concealed beneath the medial cerebral cortex. Unlike parasagittal meningiomas, it does not originate from the superior sagittal sinus (SSS) or the main dural roof, though it frequently abuts the SSS superiorly or the inferior sagittal sinus (ISS) along its free margin. The real surgical difficulty comes from its deep location between the hemispheres: it displaces the anterior or posterior cerebral arteries, pushes the cingulate gyrus, and buries critical cortical draining veins (like the veins of Trolard or Labbé, and the internal cerebral veins) along its capsule. Q. How does location along the anterior-to-posterior axis of the falx alter tumor behavior and surgical risk? Location dictates everything in falcine meningiomas: Anterior Third (Pre-coronal): Tends to grow silently to massive sizes before detection. The primary risk is traction on the A2/A3 segments of the anterior cerebral arteries (ACA) and pericallosal branches. Middle Third (Coronal to Rolandic): Presents early with focal seizures or contralateral leg weakness. The surgical risk here is highest because of the motor cortex and crucial rolandic bridging veins running directly over the tumor capsule. Posterior Third (Parieto-occipital to Torcular): Causes visual field deficits (homonymous hemianopia) or cognitive changes. Deep posterior tumors compress the vein of Galen, straight sinus, and distal PCA branches, making deep dissection treacherous. Q. How do you differentiate a true falcine meningioma from a parasagittal meningioma? It comes down to the origin of the dural base: Parasagittal Meningioma: Arises from the dural convexity immediately adjacent to or within the wall of the SSS. It involves the superior sinus wall directly and often invades or occludes the SSS lumen early. Falcine Meningioma: Arises purely from the falx curtain itself, strictly below the superior sagittal sinus. While a large falcine tumor can expand superiorly to push against the SSS, normal dural tissue or a clear arachnoid plane usually separates its origin from the sinus wall. Q. What is the vascular supply of falcine meningiomas? Primary blood supply comes from the anterior and posterior ethmoidal arteries (for anterior falcine lesions) and the anterior and posterior meningeal arteries branching from the external carotid system. Middle-third lesions receive heavy supply from the middle meningeal artery via falcine branches. As these tumors enlarge, they parasitize secondary blood supply from distal pial branches of the anterior cerebral artery (callosomarginal and pericallosal) and posterior cerebral artery. Q. How do patients with falcine meningiomas typically present? Presentation depends on location and size: Middle Third: Most common presentation is progressive contralateral lower extremity weakness (due to compression of the homunculus along the medial motor strip) or focal Jacksonian motor seizures starting in the foot or leg. Anterior Third: Patients present with cognitive slowing, personality changes, apathy, urinary incontinence (similar to normal pressure hydrocephalus or bifrontal injury), or raised ICP headaches. Posterior Third: Presents with homonymous hemianopia, visual spatial agnosia, or pressure-related headaches. Bilateral Extension: Falcine meningiomas frequently grow through the falx into both hemispheres ("dumbbell" or "saddle" shape), leading to bilateral lower limb monoparesis or paraparesis. Q. What are the key MRI and angiographic findings to evaluate before surgery? MRI (T1+C / T2 / FLAIR): Identifies the extra-axial mass attached to the falx, defines dural tailing, assesses peritumoral cortical edema, and demonstrates whether the tumor is unilateral or dumbbell-shaped across the midline. MR Venography (MRV) / Digital Subtraction Angiography (DSA): Essential to verify the patency of the Superior Sagittal Sinus, assess displacement of the Inferior Sagittal Sinus, and map critical bridging veins crossing the interhemispheric fissure. MR Angiography (MRA): Visualizes displacement, encasement, or stretching of the A2/A3 pericallosal and callosomarginal arteries. Q. What anatomical factors dictate the choice of surgical approach? The primary driver is the tumor's center of mass along the anteroposterior plane, its vertical depth relative to the SSS, and whether it is strictly unilateral or bilateral. The absolute rule in falcine surgery is to plan the craniotomy so that you arrive directly over the tumor base, avoiding unnecessary brain retraction or division of critical bridging veins. Q. What are the indications, advantages, and limitations of the standard surgical routes? Interhemispheric Approach (Standard Workhorse) Key Indications: Standard choice for the vast majority of falcine meningiomas across anterior, middle, and posterior thirds. Primary Advantages: Uses a natural anatomic plane (the interhemispheric fissure) straight down to the falx. Allows early identification of the main tumor attachment along the falx and provides direct access to debulk the mass internally without invading the cerebral cortex. Main Limitations: Working in a deep, narrow fissure with tight boundaries. Over-retraction of the medial hemisphere risks venous infarction if rolandic bridging veins are stretched or sacrificed. Transcortical / Transsulcal Approach Key Indications: Massive, deeply seated lesions with significant lateral cortical mantle thinning, or cystic components extending far into the subcortical white matter. Primary Advantages: Provides a wide, short working distance directly into the center of the tumor, bypassing a crowded interhemispheric fissure filled with critical bridging veins. Main Limitations: Requires breaching non-disrupted cerebral cortex or dissecting through a sulcus, carrying an inherent risk of post-operative seizure foci, permanent focal neurological deficit, or local encephalomalacia. Bilateral / Interhemispheric Transfalcine Approach Key Indications: Large "dumbbell" falcine meningiomas that cross the midline and occupy both cerebral hemispheres. Primary Advantages: A single craniotomy crossing the midline allows the surgeon to resect the primary tumor on the dominant side, resect the attached falx, and then work straight through the defect in the falx to remove the contralateral extension without a separate brain approach. Main Limitations: Requires crossing the SSS during bone flap removal (risk of sinus tear or air embolism) and handling dual sets of pericallosal vessels. Surgical Technique, Execution, & Intraoperative Pearls Q. Step-by-step, how do you perform an interhemispheric approach for a middle-third falcine meningioma? Positioning & Craniotomy: Supine with head elevated 15 to 20 degrees and kept strictly in neutral (or side-lying with the tumor side down to let gravity pull the hemisphere away from the falx). A rectangular craniotomy is fashioned crossing the midline to expose the edge of the SSS. Dural Opening: Open the dura in a C-shaped flap based toward the SSS. Take extreme care near the sinus border to preserve entering bridging veins. Interhemispheric Dissection: Under the microscope, gently release CSF from the callosal cisterns. Dissect the arachnoid along the interhemispheric fissure, carefully preserving every bridging vein (especially near the rolandic cortex). Devascularization & Internal Debulking: Coagulate the dural attachment on the falx around the margin of the tumor to cut off its primary blood supply. Gut the center of the tumor aggressively using an ultrasonic aspirator. Capsule Mobilization & Resection: Once the shell is thin and mobile, peel the capsule away from the surrounding cortex, identifying and preserving the A2/A3 pericallosal branches in their arachnoid planes. Cut the attachment off the falx (or resect the falx completely) and remove the specimen. Closure: Verify hemostasis along the falcine rim, perform a watertight dural closure (using a patch if needed), and secure the bone flap. Q. How does internal debulking protect the medial motor cortex and pericallosal vessels? Internal debulking is the single most important maneuver for preventing stroke and motor deficits. By hollowing out the center of the tumor, the rigid capsule collapses into itself. This creates space within the interhemispheric fissure, allowing you to peel the thin outer shell away from the brain without pushing against the surrounding motor cortex. Crucially, it allows you to dissect the pericallosal and callosomarginal arteries off the capsule under zero tension. Q. What is the management of bridging veins during an interhemispheric dissection? Bridging veins, particularly those draining the motor strip (vein of Trolard) into the SSS, must be treated as irreplaceable. Sacrifice of a major rolandic bridging vein causes venous infarction, massive brain swelling, permanent hemiplegia, or status epilepticus. Mobilize the tumor around the veins rather than sacrificing them. If a vein is tethered to the capsule, dissect the tumor off the vein or leave a small cuff of tumor capsule attached to the vessel. Q. When should you resect the falx versus leaving it intact? Resect the Falx (Simpson Grade 1): Indicated when the tumor is unilateral or dumbbell-shaped and the falx is hypervascular, thick, or tumor-infiltrated. Cutting a wide margin of falx around the origin drastically reduces the risk of long-term recurrence. Leave the Falx Intact (Simpson Grade 2/3): Indicated when the tumor is easily peeled off the dural surface, when the falx is intimately attached to the deep ISS or straight sinus, or when aggressive dural resection risks injuring contralateral pericallosal vessels or bridging veins. Q. When is planned subtotal resection indicated over radical excision? Planned subtotal resection is the correct choice when the tumor capsule is densely adherent to the pericallosal/callosomarginal arteries, when it encases deep draining veins (like the ISS or internal cerebral veins), or when it is firmly bound to the eloquent motor cortex. Stripping a vessel or tearing a deep vein to achieve a "gross total resection" leads to catastrophic stroke or severe disability. The thin remnant left behind can be safely followed or treated with stereotactic radiosurgery. Q. What are the primary causes of immediate versus delayed postoperative neurological deterioration? Immediate Deterioration: Caused by surgical trauma to the primary motor cortex, intraoperative arterial occlusion/spasm of the pericallosal or callosomarginal arteries, acute venous infarction from sacrifice or thrombosis of a major rolandic bridging vein, or acute interhemispheric hematoma. Delayed Deterioration: Caused by progressive venous infarction edema (peaks at 48–72 hours), delayed ACA territory ischemic stroke, post-resection seizures/status epilepticus, or hydrocephalus. Q. What clinical and surgical factors predict postoperative neurological recovery? Favorable Prognosis: Younger age, short symptom duration, soft tumor consistency allowing easy debulking, preservation of all major bridging veins and pericallosal branches, and absence of deep cortical invasion or severe preoperative peritumoral edema. Unfavorable Prognosis: Long-standing preoperative motor deficits, dense tumor encasement of the pericallosal arteries, requirement for bridging vein sacrifice, firm or calcified tumor texture, and extensive preoperative edema on FLAIR sequences. Q. What other postoperative complications can occur, and how are they managed? Seizures: Very common due to intraoperative manipulation of the medial motor strip. Patients are routinely placed on prophylactic anti-seizure medications (e.g., levetiracetam) in the perioperative period. Venous Thrombosis & Edema: Managed with head elevation, strict avoidance of dehydration, and aggressive steroid tapering. CSF Leak & Hydrocephalus: Can occur if the frontal sinus was breached or if deep subarachnoid blood disturbs CSF resorption. Managed with lumbar drainage or permanent shunting if persistent. Q. What is the role of adjuvant radiotherapy, what are recurrence rates, and what is the follow-up protocol? Adjuvant Radiotherapy / SRS: Indicated for subtotal resections, recurrences, WHO Grade 2 (atypical) or Grade 3 (anaplastic) tumors, or tumors with high-risk molecular features (TERT promoter mutations, CDKN2A/B deletions). Stereotactic Radiosurgery (SRS) is excellent for small, residual falcine remnants. Recurrence Rates: Low (around 10% at 10 years) for Simpson Grade 1 resections of WHO Grade 1 tumors. Recurrence jumps to 20–30% for Simpson Grade 2/3 resections and is significantly higher for Grade 2/3 histology. Follow-up Protocol: Baseline contrast-enhanced MRI within 48 hours post-op. For WHO Grade 1 GTR, perform serial MRIs at 6 months, 12 months, and then annually for 5 to 10 years. For subtotal resections or higher-grade tumors, repeat imaging every 3 to 6 months with early multidisciplinary discussion for radiosurgery.

SPINE Cervical Laminectomy Cervical Laminoplasty Cervical Stenosis and CSM Cervical Disc Disease Cervical Lateral Mass Screw Fixation Failed Back Surgery Syndrome Lumbar Canal Stenosis Lumbar Disc Disease Occipitocervical Fusion OPLL Posterior Cervical Foraminotomy Spine Long Cases/TOACS Spinal Screw Summary Thoracic Costotransversectomy Approach Transoral Odontoidectomy Treatment of Subaxial Cervical Spine Injuries

Explore occult spinal dysraphism with The Neurosurgical Case Room (TNCR), including tethered cord, filar pathology, clinical features, imaging and principles of surgical management. Occult Spinal Dysraphisms & Filar Pathologies This Section includes: Meningocele Dermal Sinus Filar Lipoma Tight Filum Terminal Myelocystocele MENINGOCELE: Q. What is a meningocele? A meningocele is a closed spinal dysraphism consisting of a CSF-filled sac that herniates through a posterior bony defect, but contains no neural tissue. The spinal cord remains within the canal, and the sac is covered by skin. It results from failure of dorsal vertebral arch formation with intact neural tube closure. Q. How does a child with meningocele present clinically? Most present with a midline, skin-covered swelling in the lumbosacral region. Neurological examination is typically normal because neural elements do not herniate into the sac. However, some children may have associated anomalies such as tethered cord, split cord malformation, or dermal sinus, so subtle motor, bladder, or foot abnormalities may coexist. Q. How is a meningocele managed? MRI is performed to confirm absence of neural tissue in the sac and to evaluate associated dysraphism. Surgical treatment involves simple excision of the meningocele sac and watertight dural closure. Because the cord is not included, neurological risk is low. Associated anomalies (e.g., tethered cord, dermal sinus, SCM) must be identified and addressed accordingly. DERMAL SINUS TRACT: Q. What is a dermal sinus tract? A dermal sinus tract is a congenital epithelial-lined channel extending from the skin surface toward the underlying neural elements due to failure of complete dysjunction between surface ectoderm and neural ectoderm during primary neurulation. It may terminate in subcutaneous tissue, dura, thecal sac, or even attach to the spinal cord, and frequently coexist with dermoid or epidermoid inclusion tumors. Q. How does a dermal sinus tract present clinically? Clinically, it appears as a midline skin dimple or pit, often with hair, discharge, or recurrent local infection. Neurological findings may result from tethered cord or inclusion tumors. Recurrent meningitis or abscess is a classic presentation because the tract provides a direct path for infection from the skin to the thecal sac. Q. How is a dermal sinus tract managed? Management is complete surgical excision of the tract using microsurgical techniques with intradural exploration to remove any associated dermoid/epidermoid tumor and to detether the cord. Early surgery is recommended even if asymptomatic because of the high risk of meningitis and progressive neurological decline. FILAR LIPOMA: Q. What is a filar lipoma? A filar lipoma is a fatty infiltration of the filum terminale, caused by abnormal differentiation of caudal mesenchyme during secondary neurulation. It may tether the conus and restrict its ascent, often associated with a low-lying conus. Q. How does a filar lipoma present clinically? Most are asymptomatic early in life but may later present with tethered cord symptoms such as back pain, gait issues, foot deformities, scoliosis, or bladder dysfunction. Many are discovered incidentally during MRI for other reasons. Q. How is a filar lipoma managed? Treatment is surgical sectioning of the filum terminale when symptomatic or when imaging demonstrates a low conus with evidence of tethering. Surgery is straightforward and carries low neurological risk because the filum contains no functional neural elements. TIGHT FILUM TERMINALE: Q. What is a tight filum terminale? A tight filum terminale is an abnormally thickened, inelastic filum that tethers the conus medullaris, typically defined as a filum >2 mm in diameter. It may or may not contain fat and results from disordered canalization during secondary neurulation. Q. How does a tight filum present clinically? Children may present with tethered cord symptoms (leg pain, gait disturbance, urinary symptoms, or foot deformities) despite a skin-covered back. MRI often shows a low-lying conus (below L2–L3) and a thickened filum without a large lipomatous mass. Q. How is a tight filum managed? Management is simple filum sectioning through a small laminotomy. Intraoperative stimulation is used to confirm the structure is non-functional. Sectioning releases the tethering and prevents progression of neurological and urological deficits. TERMINAL MYELOCYSTOCELE: Q. What is a terminal myelocystocele? A terminal myelocystocele is a closed, skin-covered spinal dysraphism resulting from a failure of secondary neurulation, in which the distal spinal cord balloons outward into a CSF-filled terminal cyst that extends dorsally through a posterior bony defect while maintaining continuity with a low-lying conus. It characteristically shows a “trumpet-like” flaring of the distal spinal cord on MRI. Q. How does a child with terminal myelocystocele present clinically? Children typically present at birth with a lumbosacral midline mass covered with normal or stretched skin. The conus is low and tethered, so progressive neurological or urological symptoms can appear with growth (leg weakness, gait disturbance, foot deformities, or neurogenic bladder). Associated anomalies are common, including anorectal malformations and urogenital anomalies. Q. How is a terminal myelocystocele managed surgically? MRI defines the anatomy. Surgery involves untethering of the cord, decompression of the terminal cyst, and reconstruction of the distal neural tube. The cyst is opened, the distended terminal cord is reduced and contoured, and a generous duraplasty is performed to prevent further tethering. The wound is closed in layered fashion. Early surgery is favored to avoid progression of neurological deficits.

Explore Dandy-Walker malformation with The Neurosurgical Case Room (TNCR), including classification, clinical presentation, imaging, associated hydrocephalus and principles of management. Dandy-Walker Malformation Dandy–Walker malformation is a congenital posterior fossa anomaly characterized by: Markedly enlarged posterior cranial fossa, Partial or complete aplasia of the cerebellar vermis, and Cystic dilatation of the fourth ventricle, which expands posteriorly into the enlarged fossa. The posterior fossa is often described as “deformed and wrapped in a neuroglial–vascular membrane.” Hydrocephalus is common. Q. What is the embryological basis of DWM? DWM results from developmental arrest/dysembryogenesis of the anterior membranous area (AMA) of the fetal rhombencephalic roof prior to the 6th–7th week of gestation. This failure of normal development prevents midline fusion of the cerebellar primordia (leading to vermian aplasia/hypoplasia) and causes persistence and cystic ballooning of the fourth ventricle. It is not caused by primary outlet obstruction/atresia of Luschka and Magendie. Q. What associated anomalies may be seen with DWM? DWM coexists with CNS and systemic abnormalities in up to 50–70% of cases: CNS Anomalies: • Corpus callosum agenesis or dysgenesis (17–50%) • Occipital encephalocele (~7%) • Neuronal migration defects (heterotopias, polymicrogyria) • Spinal dysraphism & spinal cord syrinx • Brainstem hypoplasia & microcephaly Systemic Anomalies: • Cardiac malformations (VSD, ASD, Tetralogy of Fallot) • Genitourinary anomalies (polycystic kidneys) • Craniofacial clefts • PHACE syndrome & Klippel–Feil syndrome Q. What conditions fall under the “Dandy–Walker complex”? The “Dandy–Walker Complex” includes the spectrum of posterior fossa cystic malformations: 1. Dandy–Walker malformation (DWM) 2. Dandy–Walker variant (DWV): partial features such as vermian hypoplasia or fourth ventricular cyst without posterior fossa enlargement 3. Blake’s pouch cyst (BPC): communicating 4th ventricle with posterior fossa cyst 4. Retrocerebellar arachnoid cyst: pushes cerebellum and fourth ventricle anteriorly; vermis intact 5. Joubert syndrome: vermian agenesis 6. Mega cisterna magna: enlarged cisterna with normal vermis and fourth ventricle Q. How do you differentiate DWM from other posterior fossa cystic lesions? Key Differentiating Features: • Vermis: – Severe hypoplasia/agenesis with superior/counter-clockwise rotation in DWM. – Intact (or only upwardly displaced) in Blake’s pouch cyst and arachnoid cysts. – Completely normal in mega cisterna magna. – Hypoplastic with "molar tooth" configuration of superior cerebellar peduncles in Joubert syndrome. • Fourth Ventricular Choroid Plexus: – Displaced inferolaterally or absent in the roof in DWM. – Displaced along the cyst wall/inferior to the vermis in Blake’s pouch cyst. – Normal intraventricular position (isolated from the extra-axial cyst) in arachnoid cysts. • Posterior Fossa Size & Torcula Position: – Enlarged with elevated tentorium/torcula above the lambdoid suture ("torcular-lambdoid inversion") in DWM. – Normal volume and normal torcula position in Blake’s pouch cyst, Joubert syndrome, and mega cisterna magna. • Subarachnoid Communication: – Mega cisterna magna communicates freely with CSF pathways. – DWM and retrocerebellar arachnoid cysts generally do not communicate freely with the main subarachnoid spaces. Q. What are the clinical features of Dandy–Walker malformation? Features result from hydrocephalus, posterior fossa mass effect, and associated anomalies: • Macrocephaly or enlarging head circumference • Signs of raised intracranial pressure • Developmental delay • Cerebellar signs (truncal ataxia) • Cranial nerve abnormalities in severe cases • Symptoms from associated anomalies (spinal dysraphism, encephalocele, etc.) Q. What are the radiologic features of Dandy–Walker malformation? MRI/CT hallmark features: • Large posterior fossa • Upward displacement of tentorium • Cystic dilatation of the 4th ventricle • Hypoplastic or absent vermis • Elevation of torcula and transverse sinuses (from enlarged posterior fossa) • Hydrocephalus may be present Q. What is the management of Dandy–Walker malformation? Management focuses on treating hydrocephalus, decompressing the posterior fossa cyst when necessary, and addressing associated anomalies. Hydrocephalus is usually managed with a ventriculoperitoneal shunt placed in the lateral ventricle. If both the supratentorial ventricles and the posterior fossa cyst contribute to raised pressure or remain poorly communicating, a combined diversion system can be used in which ventricular and cyst catheters are connected via a Y-connector to a single distal shunt, allowing simultaneous and balanced drainage of both compartments. Posterior fossa cysts may also be managed with fenestration into adjacent cisterns or ventricular spaces when anatomically feasible. Associated lesions such as spinal dysraphism or occipital encephalocele are treated according to standard neurosurgical principles. Long-term care includes developmental assessment, physiotherapy, and surveillance for shunt function or cyst recurrence. Q. When specifically would you use a Y-connector in DWM? I will consider a Y-connector when: Hydrocephalus persists despite ventricular shunting because the posterior fossa cyst remains tense. Posterior fossa cyst drainage alone is insufficient, causing recurrent supratentorial hydrocephalus. Imaging shows two non-communicating or poorly communicating CSF compartments: • Dilated lateral/third ventricles • A large fourth-ventricular/posterior fossa cyst Endoscopic options (e.g., cyst fenestration, ETV) are either not feasible or have failed. In these situations, a combined cyst–ventricular shunt that merges both proximal catheters via a Y-connector into a single distal VP shunt maintains balanced drainage. Q. What are the advantages of a Y-connector shunt in DWM? • Single distal shunt path reduces infection risk compared to two separate shunts. • Equal decompression of both ventricles and cyst. • Minimizes compartmental pressure gradients that can cause cyst re-expansion. • Lower shunt hardware burden than dual, independent shunts. Q. What are the disadvantages / risks? • Potential for over-drainage of the posterior fossa compartment. • Flow competition between cyst and ventricles depending on catheter positioning. • Risk of shunt obstruction at the Y-junction. • Long-term dependency on a more complex shunt system. Q. What is the prognosis for DWM? Prognosis depends on: • Degree of vermian aplasia/hypoplasia • Severity of hydrocephalus • Presence of associated CNS anomalies (such as corpus callosum agenesis, encephalocele) Children with major associated anomalies or severe hydrocephalus often have poorer developmental outcomes. Q. What are the important differential diagnoses of DWM? Dandy–Walker variant Blake’s pouch cyst Retrocerebellar arachnoid cyst Mega cisterna magna Joubert syndrome

Explore convexity meningioma with The Neurosurgical Case Room (TNCR), including clinical presentation, imaging, surgical planning, operative technique and principles of management. Convexity Meningioma A convexity meningioma is a dural-based tumor arising from the cerebral convexity dura mater, away from the major dural venous sinuses and falx. These tumors originate from the outer convex surface of the brain and grow inward toward the cortical surface, displacing but initially respecting the arachnoid plane. Their surgical behavior is primarily determined by their relationship to the underlying cortex and cortical veins rather than venous sinuses. Q. What is the cell of origin and embryologic basis of convexity meningiomas? Convexity meningiomas arise from arachnoid cap cells located within the arachnoid villi and granulations distributed along the convexity dura. These cells derive from neural crest–mesenchymal elements and retain proliferative potential throughout life. There is no distinct embryologic difference between convexity and other intracranial meningiomas, but the widespread distribution of arachnoid cap cells along the convexity explains the high frequency of tumors at this site. Q. What histopathologic subtypes and molecular features are relevant to convexity meningiomas? Common histologic subtypes include meningothelial, fibrous, and transitional meningiomas, which are typically WHO grade 1. Convexity meningiomas frequently harbor NF2 mutations and chromosome 22q deletions. Higher-grade tumors demonstrate increased mitotic activity, brain invasion, necrosis, or sheeting architecture and show more complex molecular alterations that correlate with aggressive behavior and recurrence. Q. What is the epidemiology and incidence of convexity meningiomas? Convexity meningiomas are among the most common intracranial meningiomas, accounting for approximately 30 percent of cases. They typically occur in middle-aged and elderly patients and show a female predominance. Their frequency reflects the large surface area of the cerebral convexity and the widespread distribution of arachnoid cap cells. Q. What is the natural history and growth behavior of convexity meningiomas? Convexity meningiomas generally grow slowly and remain asymptomatic for long periods. Progressive enlargement leads to mass effect on the adjacent cortex, resulting in seizures, focal neurological deficits, or raised intracranial pressure. Unlike parasagittal tumors, venous sinus compromise is uncommon, but cortical vein involvement may contribute to edema and neurological symptoms. Untreated tumors may eventually cause significant morbidity due to cortical compression and edema. Q. How are convexity meningiomas anatomically distributed, and how does location influence clinical presentation? Convexity meningiomas arise over the frontal, parietal, temporal, or occipital lobes: Frontal Convexity: Most common; often grow very large before detection, presenting with executive dysfunction, personality changes, or generalized seizures. Parietal Convexity: Frequently present early with contralateral sensory deficits, apraxia, or focal motor seizures. Temporal Convexity: Produce seizures, memory impairment, or sensory aphasia if the dominant hemisphere is involved. Occipital Convexity: Typically present with contralateral homonymous visual field deficits. Overall, seizures are the most common presenting symptom across all sites, while headaches and signs of raised intracranial pressure occur with larger tumors causing mass effect. Q. What key surgical anatomy, arachnoid planes, and cortical vein relationships dictate operative complexity and intraoperative risks? The key surgical anatomy comprises the convexity dura, the underlying cortex, the intervening arachnoid plane, and superficial cortical veins. Arachnoid Plane: Initially, the tumor displaces the cortex while respecting the arachnoid plane. Attenuation or loss of this plane, especially in higher-grade tumors, leads to cortical adherence or frank brain invasion. Preserving this plane during dissection avoids cortical contusion and seizures. Cortical Veins: Cortical veins are frequently stretched, displaced, or encased along the tumor margin. Sacrifice or traction injury to these veins can lead to severe venous infarction, edema, and hemorrhage. Intraoperative risks are directly tied to these structures and are minimized by gentle handling, maintaining natural dissection planes, avoiding brain retraction, and performing early internal debulking. Q. What are the characteristic CT features of convexity meningiomas? On CT imaging, convexity meningiomas typically appear as well-circumscribed, hyperdense extra-axial masses along the cerebral convexity. Calcification may be present, particularly in long-standing tumors. Hyperostosis or focal thickening of the adjacent calvarium is common and reflects chronic dural involvement. CT also demonstrates mass effect, midline shift, and associated vasogenic edema, which may be disproportionate to tumor size in some cases. Q. What are the MRI characteristics of convexity meningiomas? On MRI, convexity meningiomas are usually isointense to slightly hypointense on T1-weighted images and iso- to hyperintense on T2-weighted images. They show intense, homogeneous enhancement following contrast administration and often demonstrate a dural tail. MRI accurately delineates the tumor–brain interface, cortical involvement, venous relationships, and the extent of peritumoral edema, all of which are critical for surgical planning. Q. What imaging features suggest brain invasion or aggressive behavior in convexity meningiomas? Imaging features suggestive of brain invasion or higher-grade behavior include irregular or lobulated tumor margins, loss of the cerebrospinal fluid cleft, heterogeneous enhancement, extensive peritumoral edema, and cortical signal changes adjacent to the tumor. These findings correlate with histologic brain invasion and are associated with increased recurrence risk. Q. What are the important differential diagnoses of convexity lesions? Differential diagnoses include dural metastasis, solitary fibrous tumor or hemangiopericytoma, lymphoma, glioma with dural contact, and granulomatous lesions. Features favoring meningioma include broad-based dural attachment, hyperostosis, homogeneous enhancement, and a dural tail. Q. What are the overall management principles, decision criteria for extent of resection, and application of Simpson grading in convexity meningiomas? The goal of management is complete surgical resection while preserving neurological function. Because convexity meningiomas are superficial and accessible, Simpson Grade I or II resection (complete tumor excision, coagulation/excision of involved dura, and resection of hyperostotic bone) is often achievable and provides low long-term recurrence rates. The decision between gross total resection and subtotal resection is guided by: Cortical & Venous Adherence: If the tumor is densely adherent to eloquent cortex or critical cortical veins without a clear arachnoid plane, subtotal resection is preferred to prevent severe neurological deficits or venous infarction. Tumor Location & Functional State: Non-eloquent locations permit aggressive Simpson Grade I resection, whereas eloquent cortex demands a conservative approach along adherent interfaces. Q. How will you surgically manage a convexity meningioma? I will position the patient according to tumor location to allow gravity-assisted brain relaxation. Guided by neuronavigation, I will perform a tailored convexity craniotomy centered over the lesion that provides adequate exposure while minimizing brain retraction. I will open the dura in a curvilinear fashion hinged on the dural base. I will devascularize the tumor at its dural origin, perform thorough internal debulking to collapse the capsule, and carefully dissect the tumor wall away from the underlying cortex along the arachnoid plane. I will meticulously identify and preserve all cortical veins. Involved dura and hyperostotic bone will be excised when safe to achieve a low Simpson grade before completing a primary or graft dural closure. Q. What immediate and delayed complications, including long-term morbidity, can occur after convexity meningioma surgery? Immediate Complications: Postoperative seizures, transient or permanent focal neurological deficits, acute intraventricular or parenchymal hemorrhage, cerebral edema, and wound complications. Delayed Complications & Long-Term Morbidity: Persistent epilepsy, delayed venous infarction from intraoperative venous compromise, chronic headaches, and subtle personality or executive function deficits (particularly following frontal resections). Higher-grade tumors or subtotal resections also carry a risk of late recurrence. Q. What is the role of radiotherapy, and how are residual or recurrent convexity meningiomas managed? Management of residual or recurrent tumors depends on growth rate, symptoms, patient status, and WHO grade: Observation: Small, asymptomatic WHO grade 1 remnants may be followed with serial imaging. Reoperation: Feasible and preferred for enlarging or symptomatic recurrent tumors in accessible locations, though surgical risk is higher due to scarring and venous adherence. Radiation Therapy / SRS: Stereotactic radiosurgery (SRS) is indicated for small residual/recurrent lesions away from critical cortex or in patients unfit for reoperation. Fractionated radiotherapy is used for larger tumor volumes, WHO grade 2 (atypical), or WHO grade 3 (anaplastic) meningiomas to improve local tumor control. Q. What factors influence prognosis in convexity meningiomas? Prognosis is influenced primarily by WHO grade, extent of resection, presence of brain invasion, and molecular features. Simpson grade I or II resection is associated with excellent long-term control in WHO grade 1 tumors. Higher-grade tumors have increased recurrence risk and require closer surveillance and adjuvant therapy. Q. What are the expected long-term outcomes and quality-of-life considerations in convexity meningioma patients? Most patients with WHO grade 1 convexity meningiomas achieve good long-term survival and functional independence. Quality of life is determined by seizure control, preservation of neurological function, and avoidance of recurrence. Patients with higher-grade tumors may experience chronic morbidity related to repeated treatments. Q. What follow-up and surveillance protocol do you recommend after treatment of convexity meningioma? I recommend early postoperative MRI to establish a baseline, followed by surveillance imaging at six months and annually thereafter for WHO grade 1 tumors. More frequent imaging is advised for higher-grade tumors or subtotal resections. Long-term clinical follow-up focuses on neurological status, seizure control, and early detection of recurrence.

Explore lipomyelomeningocele with The Neurosurgical Case Room (TNCR), including embryology, clinical presentation, imaging, tethered cord and principles of surgical management. Lipomyelomeningocele A lipomyelomeningocele is a closed, skin-covered spinal dysraphism in which a subcutaneous lipoma extends through a bony defect and intermingles with the neural placode, causing tethering of the spinal cord. The neural placode–lipoma interface lies outside the spinal canal because the dura is expanded into a sac-like configuration. Q. How does lipomyelomeningocele differ from lipomyelocele? The key difference lies in the position of the placode-lipoma interface: In lipomyelomeningocele, the placode–lipoma junction lies outside the spinal canal, and the dura forms a meningocele-like expansion. In lipomyelocele, the placode–lipoma interface remains within the spinal canal, and the dorsal defect is smaller with no significant dural expansion. Both represent premature dysjunction with mesenchymal invasion, but lipomyelomeningocele is anatomically more externalized. Q. What is the embryological basis of lipomyelomeningocele? It arises from premature dysjunction i.e. the surface ectoderm separates from neural ectoderm too early during primary neurulation. This allows mesenchymal fat cells to invade the open neural plate, becoming incorporated into the forming spinal cord. As the cord closes, the fat remains attached, creating a tethering lipoma that extends out through a bony defect. Q. How does a child with lipomyelomeningocele typically present? Most children present with a skin-covered subcutaneous mass in the lumbosacral area, often with associated cutaneous markers such as a fatty lump, skin discoloration, or asymmetric gluteal cleft. Neurological deficits may be absent initially, but progressive tethered cord symptoms develop with growth, including gait disturbance, lower limb weakness, foot deformities, scoliosis, back pain, and urological deterioration such as neurogenic bladder. Dermal sinus tracts or infection may occur if associated epithelial elements are present. Q. What imaging features suggest lipomyelomeningocele? MRI is diagnostic. It shows: A subcutaneous fat mass entering the spinal canal. A thickened filum or lipoma attached to the neural placode. The placode–lipoma interface located outside (in LMM) or inside (in LMC) the spinal canal. Low-lying conus, usually below L2–L3. Expanded dorsal dura in lipomyelomeningocele. CT may show a posterior bony defect. MRI also evaluates associated tethered cord, syringomyelia, or split cord malformation. Q. What are the indications for surgery in lipomyelomeningocele? Surgery is indicated in: Progressive neurological deficits Urological deterioration on urodynamics Orthopedic changes such as cavovarus foot or scoliosis Documented tethered cord Symptomatic or enlarging lipoma Some surgeons also advocate prophylactic early surgery due to progressive tethering expected with growth, although timing varies by center. Q. How will you surgically repair a lipomyelomeningocele? I will position the child prone and mark the midline carefully. After sterile preparation, I will perform a midline skin incision over the subcutaneous lipoma and reflect the skin flaps to expose the fatty mass. I will dissect the lipoma circumferentially, identifying its deep extension into the spinal canal through the bony defect. Using the microscope, I will remove surrounding fat until I clearly identify the lipoma–placode interface. I will perform a laminotomy around the defect as needed to expose the dura. I will open the dura longitudinally and tack it laterally. I will then identify the neural placode and inspect its attachment to the lipoma. I will use sharp microsurgical dissection to separate the lipoma from the neural tissue, preserving all functional nerve roots. I will follow the lipoma cranially and caudally until the tethering component is released. I will debulk the lipoma internal to the canal while avoiding traction on neural structures. Once I free the placode from the lipoma, I will reconstruct the neural placode by approximating its medial edges. I will perform a generous dural expansion (duraplasty) using autologous or synthetic graft material to create a capacious dural sac that prevents retethering. I will achieve meticulous hemostasis and close the dura in a watertight manner. Finally, I will close muscle, fascia, subcutaneous tissue, and skin in layered fashion to provide robust coverage. Q. What perioperative complications can occur during surgery for lipomyelomeningocele? Perioperative complications include injury to the neural placode or exiting nerve roots during lipoma–placode dissection, leading to new motor or sensory deficits. Excessive bleeding from epidural veins or the lipoma can obscure the field. Dural tears outside the planned opening can make watertight closure difficult and predispose to CSF leak. Inadequate duraplasty or failure to create a capacious dural sac can leave the cord under tension and risk early retethering. Anesthetic issues in the prone position, hypothermia in small children, and hemodynamic instability can also complicate the procedure. Q. What postoperative complications may follow lipomyelomeningocele repair? Postoperative complications include CSF leak, pseudomeningocele, wound dehiscence, and wound infection or meningitis. New or worsened neurological deficits may appear if roots or cord have been injured or compressed. There is a significant long-term risk of retethering due to scarring at the placode–dural interface, which may present with recurrent pain, new weakness, foot deformity, or bladder deterioration. Progressive spinal deformity, particularly scoliosis or lordosis, can develop with growth. Urological complications may persist or worsen despite adequate detethering, requiring ongoing urology follow-up. Q. How will you counsel the parents of a child with lipomyelomeningocele pre-operatively? I will explain that lipomyelomeningocele is a congenital fatty mass attached to the spinal cord, causing tethering that can worsen with growth. I will clarify that the aim of surgery is to release the tethering, separate the lipoma from the neural tissue as safely as possible, and expand the dura to reduce the risk of future tethering. I will emphasize that surgery is intended primarily to stabilize or slow progression, not to guarantee neurological improvement, and that pre-existing deficits, especially bladder dysfunction, may not fully recover. I will discuss perioperative risks including CSF leak, infection, and possible new weakness or sensory changes. I will stress the need for long-term follow-up with neurosurgery, urology, and orthopedics, warn about the possibility of retethering and further surgery in the future, and address their questions about walking potential, schooling, and continence in realistic but reassuring terms. Q. What is the prognosis of lipomyelomeningocele? Prognosis depends on preoperative neurological status. Early surgery offers better stabilization of motor and bladder function, but lifelong risk of retethering remains. Most children require long-term orthopedic and urological follow-up. Outcomes are generally better when surgery is performed before neurological decline. Q. Are there any recent advancements in the management of lipomyelomeningocele? Recent advancements focus on safer detethering and better long-term control of retethering. Intraoperative neurophysiological monitoring of motor and sensory pathways helps distinguish functional neural tissue from lipoma during dissection, reducing the risk of new deficits. High-resolution MRI and careful preoperative mapping improve understanding of the placode–lipoma interface. Modern duraplasty materials and techniques aim to create a generous, non-constricting dural sac to delay or reduce retethering. There is also increasing emphasis on early MRI-based screening, structured urodynamic follow-up, and multidisciplinary management protocols integrating neurosurgery, urology, and orthopedics to preserve function over time.

Review neurosurgical infections with The Neurosurgical Case Room (TNCR), covering intracranial and spinal infections, diagnosis, complications and principles of medical and surgical management. Infections Cerebral Abscess → Intracranial Fungal Granuloma → Subdural Empyema →

Explore TNCR Review Notes, concise exam-focused neurosurgery notes designed primarily for FCPS preparation and quick revision by neurosurgical residents and early-career consultants. TNCR RAPID REVIEW Please note that these review notes were primarily developed on the pattern of Exit Exams for FCPS and MS Neurosurgery. They are not a replacement for textbooks, but a brilliant way for last minute revision. Congenital Cranial Tumors & Tumor-like Lesions Vascular Infections Spine Spinal Tumors Trauma Miscellaneous